Anti‐inflammatory agents in the treatment of bipolar depression: a systematic review and meta‐analysis

JD Rosenblat, R Kakar, M Berk, LV Kessing… - Bipolar …, 2016 - Wiley Online Library
Objective Inflammation has been implicated in the risk, pathophysiology, and progression of
mood disorders and, as such, has become a target of interest in the treatment of bipolar …

Revisiting inflammation in bipolar disorder

GR Fries, C Walss-Bass, ME Bauer… - … Biochemistry and Behavior, 2019 - Elsevier
Bipolar disorder (BD) has been associated with immune changes, and yet their underlying
mechanisms are still not fully understood. Here, we review the current state of the field …

A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression

DR Goldsmith, MH Rapaport, BJ Miller - Molecular psychiatry, 2016 - nature.com
Schizophrenia, bipolar disorder and major depressive disorder (MDD) have all been
associated with aberrant blood cytokine levels; however, neither the pattern of cytokine …

Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and …

AK Wang, BJ Miller - Schizophrenia bulletin, 2018 - academic.oup.com
Introduction: Schizophrenia, bipolar disorder, and major depressive disorder (MDD) have all
been associated with immune system dysfunction, including aberrant cerebrospinal fluid …

Bipolar disorder and inflammation

JD Rosenblat, RS McIntyre - Psychiatric Clinics, 2016 - psych.theclinics.com
Methods For this narrative clinical overview, the MEDLINE/PubMed, Embase, Google
Scholar and ClinicalTrials. gov databases were searched from inception through June 2015 …

[HTML][HTML] Neuropathology of mood disorders: do we see the stigmata of inflammation?

N Mechawar, J Savitz - Translational psychiatry, 2016 - nature.com
A proportion of cases with mood disorders have elevated inflammatory markers in the blood
that conceivably may result from stress, infection and/or autoimmunity. However, it is not yet …

Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

D Baumeister, S Ciufolini, V Mondelli - Psychopharmacology, 2016 - Springer
Rationale Current psychotropic medications have been shown to modulate immune
activation. However, the effects of individual psychotropic agents on the immune system and …

Neuroinflammation and cognition across psychiatric conditions

C Fourrier, G Singhal, BT Baune - CNS spectrums, 2019 - cambridge.org
Cognitive impairments reported across psychiatric conditions (ie, major depressive disorder,
bipolar disorder, schizophrenia, and posttraumatic stress disorder) strongly impair the …

[HTML][HTML] Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive …

K Recourt, P de Boer, P van der Ark, H Benes… - Translational …, 2023 - nature.com
JNJ-54175446 is a selective purine P2X7 receptor (P2X7R) antagonist that attenuates
microglial IL-1β/IL-18 release. In healthy volunteers, JNJ-54175446 suppressed peripheral …

A comparison of the neutrophil-lymphocyte, platelet-lymphocyte and monocyte-lymphocyte ratios in schizophrenia and bipolar disorder patients–a retrospective file …

S Özdin, G Sarisoy, Ö Böke - Nordic journal of psychiatry, 2017 - Taylor & Francis
Abstract Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and monocyte-
lymphocyte ratio (MLR) have recently been used as indicators of inflammation. Higher MLR …